Search for: "Big "O" Express, Inc." Results 241 - 253 of 253
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]
7 Feb 2008, 10:46 am
" Id. at 513 (concurring and dissenting opinion).Sure, Lohr involved express medical device preemption, but the issue of what is "different from" an FDA requirement isn't all that far from the implied preemption question of whether there's a "conflict" with an FDA action. [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma… [read post]
18 Oct 2007, 7:27 am
" As we've just finished discussing, the text of §355(o)(4)(I) seems clear enough as to what it affects and what it doesn't. [read post]
9 Aug 2007, 5:53 am
While the FDA certainly has a big role to play, the importance of that role can be exaggerated, and we think the DC Circuit did so here. [read post]
2 Jul 2007, 1:04 am
Still, a big move in the pro bono rankings is the exception. [read post]
26 Jun 2007, 1:44 am
ALM Privacy Policy / Contact Us © 2007 ALM Properties, Inc. [read post]
10 Apr 2007, 1:14 am
ALM Privacy Policy / Contact Us © 2007 ALM Properties, Inc. [read post]
9 Jan 2007, 2:10 pm
Supreme Court's 8-1 ruling in favor of MedImmune (MedImmune, Inc. v. [read post]